EQS-News: Formycon AG / Key word(s): Regulatory Approval Formycon and Fresenius Kabi announce MHRA approval for FYB202/Otulfi® ...

Newron Pharmaceuticals S.p.A. ("Newron”) (SIX: NWRN, XETRA: NP5), a biopharmaceutical company focused on the development of novel therapies for ...